Showing results (391-400 of 419) with videos related to
Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.International Journal of Radiation Oncology, Biology, Physics|September 23, 2008
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3)Georg A Bjarnason, Robert G Mackenzie, Abdenour Nabid, et al.American Journal of Preventive Medicine|September 24, 2021
Evaluation of a Pharmacists' Patient Care Process Approach for HypertensionMark D Rivera, Mihaela Johnson, Hae Mi Choe, et al.ESMO Open|March 4, 2023
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicinesG Zarkavelis, A L Amylidi, C Verbaanderd, et al.Ophthalmology Science|October 24, 2022
Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring TreatmentJimmy S Chen, Jamie E Anderson, Aaron S Coyner, et al.Circulation|January 9, 2014
Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse modelNa Li, David Y Chiang, Sufen Wang, et al.Journal of Cellular Physiology|March 11, 2024
Running a successful STEMM summer program: A week-by-week guideHeather K Beasley, Zer Vue, Melanie R McReynolds, et al.Scientific Reports|October 18, 2023
Use of transcranial low-intensity focused ultrasound for targeted delivery of stem cell-derived exosomes to the brainJ Haroon, K Aboody, L Flores, et al.American Journal of Medical Genetics. Part A|March 5, 2015
FBN1 contributing to familial congenital diaphragmatic herniaTyler F Beck, Philippe M Campeau, Shalini N Jhangiani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS riskM Spina, Z Nagy, J M Ribera, et al.Pageof 42